50th Volume Reprints
The year 2023 marked the 50th year of publication of The Journal of Rheumatology. To celebrate this milestone, we looked back on our history from inception to 2023, highlighted several significant accomplishments, examined the special features published to mark the occasion, and considered the future
Below you will find the articles The Journal reprinted throughout 2023 for their impact on the field of rheumatology.
1970s
"HLA B27 in Ankylosing Spondylitis: Differences in Frequency and Relative Risk in American Blacks and Caucasians" by M. A. Khan, W. E. Braun, I. Kushner, D. E. Grecek, W. Angus Muir and A. G. Steinberg
"Evaluation of a Clinic Education Program for Patients with Rheumatoid Arthritis" by Paul J. Vignos Jr., William T. Parker and Helen M. Thompson
1980s
“Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee” by N. Bellamy, W. W. Buchanan, C. H. Goldsmith, J. Campbell and L. W. Stitt
“Primary antiphospholipid syndrome” by D. Alarcón-Segovia and J. Sanchez-Guerrero
“The measurement of helplessness in rheumatoid arthritis. The development of the arthritis helplessness index” by P.M. Nicassio, K.A. Wallston, L.F. Callahan, M. Herbert and T. Pincus
1990s
“A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index” by S. Garrett, T. Jenkinson, L.G. Kennedy, H. Whitelock, P. Gaisford, and A. Calin
"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index” by A. Calin, S. Garrett, H. Whitelock, et al
“Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis” by P. Clements, P. Lachenbruch, J. Siebold, et al
“Preliminary criteria for classification of adult Still’s disease” by M. Yamaguchi, A. Ohta, T. Tsunematsu, et al
2000s
"Criteria for the classification of early systemic sclerosis" by E.C. LeRoy and T.A. Medsger Jr
"Systemic Lupus Erythematosus Disease Activity Index 2000" D.D. Gladman, D. Ibañez, and M.B. Urowitz
"Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis" by C.A. Wallace, N. Ruperto, and E.H. Giannini, for the Childhood Arthritis and Rheumatology Research Alliance (CARRA), The Pediatric Rheumatology International Trials Organization (PRINTO), and The Pediatric Rheumatology Collaborative Study Group (PRCSG)
2010s
“Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia” by F. Wolfe, D.J. Clauw, M.A. Fitzcharles, et al
“Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials” by R.F. van Vollenhoven, P. Emery, C.O. Bingham III, et al
“YouTube for information on rheumatoid arthritis – a wakeup call?” by A.G. Singh, S. Singh, and P.P. Singh
“Safety and efficacy of tofacitinib, an oral Janus kinase inhibitor, for the treatment of rheumatoid arthritis in open-label, longterm extension studies” by J. Wollenhaupt, J. Silverfield, E.B. Lee, et al
“An internet-based self-management program with telephone support for adolescents with arthritis: a pilot randomized controlled trial” by J.N. Stinson, P.J. McGrath, E.D. Hodnett, et al
“Longterm safety of rituximab: final report of the rheumatoid arthritis global clinical trial program over 11 years” by R.F. van Vollenhoven, R.M. Fleischmann, D.E. Furst, S. Lacey, and P.B. Lehane